DK1131071T3 - Nikotin-indeholdende farmaceutiske sammensætninger givende en hurtig transmukosale absorption - Google Patents

Nikotin-indeholdende farmaceutiske sammensætninger givende en hurtig transmukosale absorption

Info

Publication number
DK1131071T3
DK1131071T3 DK99972537T DK99972537T DK1131071T3 DK 1131071 T3 DK1131071 T3 DK 1131071T3 DK 99972537 T DK99972537 T DK 99972537T DK 99972537 T DK99972537 T DK 99972537T DK 1131071 T3 DK1131071 T3 DK 1131071T3
Authority
DK
Denmark
Prior art keywords
nicotine
formulations
pharmaceutical compositions
containing pharmaceutical
transmucosal absorption
Prior art date
Application number
DK99972537T
Other languages
English (en)
Inventor
Sven Boerje Andersson
Tomas Landh
Stefan Jonn
Stefan Persson
Nils-Olof Lindberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of DK1131071T3 publication Critical patent/DK1131071T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK99972537T 1998-11-23 1999-11-04 Nikotin-indeholdende farmaceutiske sammensætninger givende en hurtig transmukosale absorption DK1131071T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803986A SE9803986D0 (sv) 1998-11-23 1998-11-23 New compositions
PCT/SE1999/001983 WO2000030641A1 (en) 1998-11-23 1999-11-04 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption

Publications (1)

Publication Number Publication Date
DK1131071T3 true DK1131071T3 (da) 2004-05-10

Family

ID=20413363

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99972537T DK1131071T3 (da) 1998-11-23 1999-11-04 Nikotin-indeholdende farmaceutiske sammensætninger givende en hurtig transmukosale absorption

Country Status (12)

Country Link
US (1) US6676959B1 (da)
EP (1) EP1131071B1 (da)
JP (1) JP2002530335A (da)
AT (1) ATE264102T1 (da)
AU (1) AU1434000A (da)
DE (1) DE69916486T2 (da)
DK (1) DK1131071T3 (da)
ES (1) ES2220149T3 (da)
HK (1) HK1040614B (da)
PT (1) PT1131071E (da)
SE (1) SE9803986D0 (da)
WO (1) WO2000030641A1 (da)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103210D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof
SE0103211D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof
US20030087937A1 (en) * 2001-10-15 2003-05-08 Nils-Olof Lindberg Nicotine and cocoa powder compositions
SE0202365D0 (sv) 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
DE10251963A1 (de) * 2002-11-08 2004-05-19 Lts Lohmann Therapie-Systeme Ag Transmucosale pharmazeutische Darreichungsform
US9358296B2 (en) * 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
SE0300831D0 (sv) * 2003-03-26 2003-03-26 Pharmacia Ab New formulations and use therof
SE0300830D0 (sv) * 2003-03-26 2003-03-26 Pharmacia Ab New formulations and use thereof
CN104397869B (zh) * 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
FR2882656B1 (fr) * 2005-03-07 2007-06-22 Schwartz Laboratoires Robert S Composition antitabagique
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
US7946296B2 (en) * 2006-05-26 2011-05-24 Philip Morris Usa Inc. Dissolvable tobacco film strips and method of making the same
WO2007072224A2 (en) * 2006-09-13 2007-06-28 Nara Institute Of Science And Technology Increasing levels of nicotinic alkaloids
BRPI0719428A2 (pt) * 2006-12-01 2014-02-25 Cima Labs Inc Forma de dosagem transmucosal oral sólida, método para tratar dependência de nicotina em um receptor que deseja tal tratamento, sistema de distribuição de nicotina transmucosal oral, e, método de substituíção de nicotina.
WO2008091588A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
ZA200905697B (en) * 2007-02-15 2010-10-27 Derma Young Ltd Compositions and methods for enhancing transmucosal delivery
US8356606B2 (en) * 2007-06-01 2013-01-22 Philip Morris Usa Inc. Production of micronized encapsulated tobacco particles for tobacco flavor delivery from an oral pouch
US9167835B2 (en) 2008-12-30 2015-10-27 Philip Morris Usa Inc. Dissolvable films impregnated with encapsulated tobacco, tea, coffee, botanicals, and flavors for oral products
US9167847B2 (en) 2009-03-16 2015-10-27 Philip Morris Usa Inc. Production of coated tobacco particles suitable for usage in a smokeless tobacoo product
EP2557947A1 (en) 2010-04-14 2013-02-20 Altria Client Services Inc. Preformed smokeless tobacco product
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US20230255257A1 (en) * 2010-08-11 2023-08-17 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US11116237B2 (en) * 2010-08-11 2021-09-14 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
US10799548B2 (en) 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
EP3871515B1 (en) 2014-05-27 2025-04-16 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US10881133B2 (en) 2015-04-16 2021-01-05 R.J. Reynolds Tobacco Company Tobacco-derived cellulosic sugar
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
EP4338735B1 (en) 2015-11-25 2026-02-04 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
US10499684B2 (en) 2016-01-28 2019-12-10 R.J. Reynolds Tobacco Company Tobacco-derived flavorants
US11154087B2 (en) 2016-02-02 2021-10-26 R.J. Reynolds Tobacco Company Method for preparing flavorful compounds isolated from black liquor and products incorporating the flavorful compounds
US11091446B2 (en) 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
EP4635478A3 (en) 2017-09-05 2026-01-07 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US20190307082A1 (en) 2018-04-05 2019-10-10 R.J. Reynolds Tobacco Company Oriental tobacco production methods
CN112384504A (zh) 2018-06-15 2021-02-19 R.J.雷诺兹烟草公司 烟碱的纯化
WO2021116855A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions and methods of manufacture
WO2021116865A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents for oral composition
MX2023010620A (es) 2021-03-09 2023-09-19 Nicoventures Trading Ltd Productos orales y metodos de fabricacion.
US20220354785A1 (en) 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
WO2022234522A1 (en) 2021-05-06 2022-11-10 Nicoventures Trading Limited Oral compositions and related methods for reducing throat irritation
CA3233375A1 (en) 2021-09-30 2023-04-06 Michael Zawadzki Oral product with a basic amine and an ion pairing agent
WO2023084499A1 (en) 2021-11-15 2023-05-19 Nicoventures Trading Limited Products with enhanced sensory characteristics
WO2023248187A1 (en) 2022-06-24 2023-12-28 Nicoventures Trading Limited Oral composition comprising a receptor modulator
GB202214771D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
US20260115133A1 (en) 2022-10-07 2026-04-30 Nicoventures Trading Limited Oral product
GB202214775D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
AU2023357712A1 (en) 2022-10-07 2025-04-17 Nicoventures Trading Limited Oral product
AU2023357713A1 (en) 2022-10-07 2025-04-17 Nicoventures Trading Limited Oral product
GB202214803D0 (en) 2022-10-07 2022-11-23 Nicoventures Trading Ltd Oral product
WO2024095163A1 (en) 2022-11-01 2024-05-10 Nicoventures Trading Limited Oral composition comprising encapsulated ph adjusting agent
TW202434271A (zh) 2022-11-04 2024-09-01 英商尼可創業貿易有限公司 口服產品
GB202216465D0 (en) 2022-11-04 2022-12-21 Nicoventures Trading Ltd Oral product
EP4672985A1 (en) 2023-02-28 2026-01-07 Nicoventures Trading Limited Caffeine-containing oral product
GB202304445D0 (en) 2023-03-27 2023-05-10 Nicoventures Trading Ltd Oral product
GB202307279D0 (en) 2023-05-16 2023-06-28 Nicoventures Trading Ltd Oral product
GB202307278D0 (en) 2023-05-16 2023-06-28 Nicoventures Holdings Ltd Oral product
EP4543417A1 (en) * 2023-09-12 2025-04-30 Fertin Pharma A/S Orally disintegrating nicotine tablet for use under lip
EP4585055A1 (en) 2024-01-12 2025-07-16 Nicoventures Trading Limited Oral product with probiotic component
EP4599698A1 (en) 2024-02-07 2025-08-13 Nicoventures Trading Limited Products comprising sensory agents
EP4602929A1 (en) 2024-02-19 2025-08-20 Nicoventures Trading Limited Oral product with powder coating
EP4623708A1 (en) 2024-03-26 2025-10-01 Nicoventures Trading Limited Sweetener composition for pouched oral products
EP4623702A1 (en) 2024-03-27 2025-10-01 Nicoventures Trading Limited Oral product
EP4631502A1 (en) 2024-04-12 2025-10-15 Nicoventures Trading Limited Use of flavones such as quercetin to increase cognitive function and to reduce jitterness
WO2026013602A1 (en) 2024-07-10 2026-01-15 Rai Strategic Holdings, Inc. Oral products

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783207A (en) 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
JPS62175141A (ja) * 1986-01-29 1987-07-31 Kazuo Takatsu 複合チヨコレ−ト
US5017400A (en) * 1988-06-10 1991-05-21 Suomen Xyrofin Oy Non-cariogenic sweetener
US5004601A (en) * 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5098730A (en) * 1988-11-14 1992-03-24 Cultor Ltd. Dietetic sweetening composition
US5512306A (en) * 1992-06-19 1996-04-30 Pharmica Ab Smoking substitute
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
JPH0940564A (ja) * 1995-07-26 1997-02-10 Taiyo Kagaku Co Ltd 悪酔予防改善用組成物
JPH0956333A (ja) * 1995-08-21 1997-03-04 Kozaburo Shiba 機能性梅チョコレート
JP2001518520A (ja) * 1997-10-03 2001-10-16 キャリー メディカル コーポレイション ニコチンレセプターアンタゴニストおよび抗抑うつ薬または抗不安薬を含有するニコチン嗜癖を治療する組成物

Also Published As

Publication number Publication date
ES2220149T3 (es) 2004-12-01
HK1040614B (en) 2004-10-08
PT1131071E (pt) 2004-06-30
WO2000030641A1 (en) 2000-06-02
DE69916486D1 (de) 2004-05-19
DE69916486T2 (de) 2004-08-26
HK1040614A1 (en) 2002-06-21
ATE264102T1 (de) 2004-04-15
EP1131071B1 (en) 2004-04-14
AU1434000A (en) 2000-06-13
SE9803986D0 (sv) 1998-11-23
US6676959B1 (en) 2004-01-13
JP2002530335A (ja) 2002-09-17
EP1131071A1 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
DK1131071T3 (da) Nikotin-indeholdende farmaceutiske sammensætninger givende en hurtig transmukosale absorption
IS8726A (is) Meðferðarfræðilegar samsetningar þrýstingslækkandi efna og efna sem hamla gegn æðamyndun
MXPA06000381A (es) Composicion de dulce dental antiplaca y que puede ser masticada.
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
ATE444738T1 (de) Verbesserte essbare filmformulierungen mit maltodextrin
MXPA01007411A (es) Composiciones y metodos para suministro mucoso.
MXPA03009772A (es) Metodos y composiciones para tratar lesiones orales y del esofago.
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
IL150706A0 (en) Composition and methods for the treatment of skin disorders
WO2005018605A3 (en) Novel formulation of ropinirole
TR200102385T2 (tr) Kendiliğinden çözülür N-benzoil staurosporin kompozisyonları.
EE200200471A (et) Farmatseutiline kompositsioon, mis sisaldab kamptotetsiini või selle derivaati kombinatsioonis pürimidiini derivaadiga ning on ette nähtud vähktõve raviks
IS6439A (is) Samsetningar til að meðhöndla viðnám gegn háþrýstingslyfjum
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення
IL140588A0 (en) Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents
YU36900A (sh) Intraoralni i intranazalni transmukozni preparat koji sadrži levosimendan
TR200002847T2 (tr) Biçim VI 5, 6-dikloro-2-(izopropilamino) -1-(beta-L-ribofüranosil) -1H-benzimidazol.
SE0103210D0 (sv) New formulations and use thereof
DE60016567D1 (de) Makrophagenhaltige zusammensetzung mit antiinfektiösen und hematopoietischen eigenschaften sowie deren herstellungsmethode
ES2086536T3 (es) Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
WO2002051404A8 (fr) Compositions orales
WO2004030623A3 (en) Nitroxide radioprotector formulations and methods of use
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.